![Chandra Gottschling](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chandra Gottschling
Corporate Officer/Principal at Novus Biologicals LLC
Profile
Chandra Gottschling is currently working as a Product Director at Novus Biologicals LLC since 2012.
Prior to this, Chandra completed an undergraduate degree at The University of New Mexico.
Chandra Gottschling active positions
Companies | Position | Start |
---|---|---|
Novus Biologicals LLC
![]() Novus Biologicals LLC Pharmaceuticals: MajorHealth Technology Novus Biologicals LLC develops and markets antibodies for scientific researchers in government, university, and biotech labs worldwide. It provides primary antibodies, secondary antibodies, antibody packs, lysates, peptides and proteins, antibody pairs, kits, RNAi, slides, isotype controls, support products, and various research reagents. Novus products are used in various research areas, including apoptosis, autophagy, cancer, DNA repair, epigenetics, epitope tags, GPCR, hypoxia, lipid and metabolism, loading controls, neuroscience, stem cell markers, cellular markers, immunology, and protein turnover. The company was founded by Karen M. Padgett in 1996 and is headquartered Littleton, CO. | Corporate Officer/Principal | 2009-09-01 |
Training of Chandra Gottschling
The University of New Mexico | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Novus Biologicals LLC
![]() Novus Biologicals LLC Pharmaceuticals: MajorHealth Technology Novus Biologicals LLC develops and markets antibodies for scientific researchers in government, university, and biotech labs worldwide. It provides primary antibodies, secondary antibodies, antibody packs, lysates, peptides and proteins, antibody pairs, kits, RNAi, slides, isotype controls, support products, and various research reagents. Novus products are used in various research areas, including apoptosis, autophagy, cancer, DNA repair, epigenetics, epitope tags, GPCR, hypoxia, lipid and metabolism, loading controls, neuroscience, stem cell markers, cellular markers, immunology, and protein turnover. The company was founded by Karen M. Padgett in 1996 and is headquartered Littleton, CO. | Health Technology |
- Stock Market
- Insiders
- Chandra Gottschling